secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARVINAS, INC. (ARVN)
CIK:        0001655759
Form:       8-K
Filed at:   2026-06-22T20:10:16+00:00
Accession:  0001628280-26-044627
Event type: leadership
Sentiment:  negative
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Arvinas CMO Noah Berkowitz to depart July 3, 2026; severance includes accelerated RSU vesting
--------------------------------------------------------------------------------

- Dr. Berkowitz will leave as CMO effective July 3, 2026, to pursue other opportunities.
- Company has begun a search for a new chief medical officer.
- Separation agreement provides 9 months base salary, health coverage, and accelerated vesting of RSUs vesting on or before May 9, 2027.
- All other unvested RSUs will be forfeited.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1655759/000162828026044627/0001628280-26-044627-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1655759/000162828026044627/arvn-20260622.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-044627

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer